Charlotte Leduc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Charlotte Leduc has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Elisabeth Quoix
University Hospital
2 shared publications A. Dazy
1 shared publicationA. Langlais
1 shared publicationA. Lemoine
1 shared publicationAlexandra Langlais
Department of Biostatistics, French Cooperative Thoracic Intergroup, Paris, France
1 shared publicationAngélique Robin
INSERM, UMR981, F-94805, Villejuif, France, Paris Sud University, Gustave Roussy, Villejuif, France
1 shared publication
Latest Publications
- 1 September 2021
- Published by Elsevier in L'Anthropologie
- p. 102925
WITHDRAWN: Recy « Le Mont Grenier » (Marne): Un gisement de fosses du Mésolithique
- 1 September 2021
- Published by Elsevier in L'Anthropologie
- p. 102925
WITHDRAWN: Recy « Le Mont Grenier » (Marne): Un gisement de fosses du Mésolithique
- 1 February 2020
- Published by Elsevier in Lung Cancer
- Vol. 140, 19-26
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project
- 1 February 2020
- Published by Elsevier in Lung Cancer
- Vol. 140, 19-26
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project
- Open Access
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma
Background Antiprogrammed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) therapies have demonstrated promising activity in advanced head and neck squamous cell carcinoma (HNSCC), with overall response rates of approximately 20% in unselected populations and survival benefit. Whether induction docetaxel, platinum and fluorouracil (TPF) modifies PD-L1 expression or tumour immune infiltrates is unknown. Patients and methods Patients with locally advanced HNSCC treated at Gustave Roussy (Villejuif, France) between 2006 and 2013 by induction TPF followed by surgery were retrospectively considered. Patients with paired samples (pre-TPF and post-TPF) were kept for further analysis. PD-L1 expression was quantified by immunohistochemistry according to a validated protocol. The objective of the study was to compare PD-L1 expression on tumour cells (TC) and immune cells (IC) (positivity threshold of ≥5%) before and after TPF. CD8+ and Foxp3+ lymphocytes densities before and after TPF were also quantified. Results Out of 313 patients receiving induction TPF, 86 underwent surgery; paired samples were available for 21 of them. Baseline PD-L1 expression was ≥5% in two and five samples for TC and IC, respectively. A significant increase of PD-L1 expression was observed after TPF, with 15 samples (71%) presenting a positive staining in IC after induction chemotherapy (P=0.003; Wilcoxon rank-sum test) and eight samples (38%) in TC (P=0.005; Wilcoxon rank-sum test). Tumour-infiltrating CD8+ mean densities also significantly increased post-TPF (P=0.01). There was no significant difference in Foxp3+ expression, CD8/Foxp3 ratio or correlation with outcome. Conclusion TPF induction chemotherapy in advanced HNSCC increases PD-L1 positivity on tumour-infiltrating ICs, as well as CD8+ lymphocytes density. These results warrant independent validation on larger datasets and might help therapeutic strategy in advanced HNSCC.
Open AccessTPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma
Background Antiprogrammed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) therapies have demonstrated promising activity in advanced head and neck squamous cell carcinoma (HNSCC), with overall response rates of approximately 20% in unselected populations and survival benefit. Whether induction docetaxel, platinum and fluorouracil (TPF) modifies PD-L1 expression or tumour immune infiltrates is unknown. Patients and methods Patients with locally advanced HNSCC treated at Gustave Roussy (Villejuif, France) between 2006 and 2013 by induction TPF followed by surgery were retrospectively considered. Patients with paired samples (pre-TPF and post-TPF) were kept for further analysis. PD-L1 expression was quantified by immunohistochemistry according to a validated protocol. The objective of the study was to compare PD-L1 expression on tumour cells (TC) and immune cells (IC) (positivity threshold of ≥5%) before and after TPF. CD8+ and Foxp3+ lymphocytes densities before and after TPF were also quantified. Results Out of 313 patients receiving induction TPF, 86 underwent surgery; paired samples were available for 21 of them. Baseline PD-L1 expression was ≥5% in two and five samples for TC and IC, respectively. A significant increase of PD-L1 expression was observed after TPF, with 15 samples (71%) presenting a positive staining in IC after induction chemotherapy (P=0.003; Wilcoxon rank-sum test) and eight samples (38%) in TC (P=0.005; Wilcoxon rank-sum test). Tumour-infiltrating CD8+ mean densities also significantly increased post-TPF (P=0.01). There was no significant difference in Foxp3+ expression, CD8/Foxp3 ratio or correlation with outcome. Conclusion TPF induction chemotherapy in advanced HNSCC increases PD-L1 positivity on tumour-infiltrating ICs, as well as CD8+ lymphocytes density. These results warrant independent validation on larger datasets and might help therapeutic strategy in advanced HNSCC.
- 1 September 2015
- Vol. 65 (7) , 945-9
[MANAGEMENT OF LUNG CANCER IN ELDERLY].
In France, more than 50% of patients diagnosed with lung cancer are elderly but recommendations about their management are scant. Several patient characteristics, as comorbidities, age-related physiological variations of the main body functions, or eventual long-term treatments, are predictive of survival and must consider for therapeutic decision. The Comprehensive Geriatric Assessment (CGA) is the best tool to evaluate elderly with lung cancer and to identify fit patients who are more likely to benefit from standard treatment from frail ones who are candidates for supportive care.
- 1 September 2015
- Vol. 65 (7) , 945-9
[MANAGEMENT OF LUNG CANCER IN ELDERLY].
In France, more than 50% of patients diagnosed with lung cancer are elderly but recommendations about their management are scant. Several patient characteristics, as comorbidities, age-related physiological variations of the main body functions, or eventual long-term treatments, are predictive of survival and must consider for therapeutic decision. The Comprehensive Geriatric Assessment (CGA) is the best tool to evaluate elderly with lung cancer and to identify fit patients who are more likely to benefit from standard treatment from frail ones who are candidates for supportive care.
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
- Vol. 51, S647-S648
3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
- Vol. 51, S647-S648
3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)
- Open Access
- 1 June 2015
- Published by Elsevier in Journal of Archaeological Science: Reports
- Vol. 2, 473-484
Wild boar (Sus scrofa scrofa) hunting and exploitation strategies during the Mesolithic at Les Cabônes (Ranchot Jura, France), layer 3
- 1 June 2015
- Published by Elsevier in Journal of Archaeological Science: Reports
- Vol. 2, 473-484
Open AccessWild boar (Sus scrofa scrofa) hunting and exploitation strategies during the Mesolithic at Les Cabônes (Ranchot Jura, France), layer 3
- 1 April 2015
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 55 (2) , 57-63
Étude à long terme de l’efficacité de différents supports textiles imprégnés d’acaricides dans le contrôle des allergènes d’acariens en conditions réelles
- 1 April 2015
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 55 (2) , 57-63
Étude à long terme de l’efficacité de différents supports textiles imprégnés d’acaricides dans le contrôle des allergènes d’acariens en conditions réelles